作者: Ehab M. Kamel , Matthias T. Wyss , Mathias K. Fehr , Gustav K. von Schulthess , Gerhard W. Goerres
DOI: 10.1007/S00432-003-0424-Z
关键词: Nuclear medicine 、 Fluorodeoxyglucose positron emission tomography 、 In patient 、 Tumor marker 、 Primary treatment 、 Breast cancer 、 Positron emission tomography 、 Mammary gland 、 Medicine
摘要: Aim To evaluate the role of [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients presenting with a suspicion breast cancer relapse after primary treatment.